Prescription drug · BLA
Ebglyss (Lebrikizumab-lbkz) NDC 0002-7797
Lebrikizumab 250 mg/2mL · Injection, Solution · Subcutaneous · Eli Lilly and Company
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0002-7797-11 | 00002779711 | 1 SYRINGE in 1 CARTON (0002-7797-11) / 2 mL in 1 SYRINGE (0002-7797-01)Marketed from Sep 13, 2024 | |
| 0002-7797-61 | 00002779761 | 1 SYRINGE in 1 CARTON (0002-7797-61) / 2 mL in 1 SYRINGEMarketed from Sep 13, 2024 · Sample package |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Ebglyss
- Generic name (nonproprietary)
- lebrikizumab-lbkz
- Active ingredients
- Lebrikizumab — 250 mg/2mL
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Labeler
- Eli Lilly and CompanyNDC labeler code 0002
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 761306
- Marketing start
- Listing expires
- Other FDA classes
- Interleukin-13 Antagonists (Mechanism)
- Identifiers
- Product ID 0002-7797_361eb12f-8b25-4174-a653-5b857e6abd03SPL ID 361eb12f-8b25-4174-a653-5b857e6abd03SPL set ID 7a774ea2-acde-4aaa-9a8f-ccba5a5b1d5fRxCUI 2693784, 2693791, 2693903, 2693907UNII U9JLP7V031
- Pharmacologic class
- Interleukin-13 Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400002779711followed by a unit qualifier and the quantityPackage 00002-7797-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
EBGLYSS is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and pediatric patients 12 years of age and older who weigh at least 40 kg whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. EBGLYSS can be used with or without topical corticosteroids. EBGLYSS ® is an interleukin-13 antagonist indicated for the treatment of moderate-to-severe atopic dermatitis in adults and pediatric patients 12 years of age and older who weigh at least 40 kg whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. EBGLYSS can be used with or without to…
Excerpt only. Read the full label for complete information.
About NDC 0002-7797
- What is NDC 0002-7797?
- 0002-7797 is the product NDC for Ebglyss (lebrikizumab-lbkz), Lebrikizumab 250 mg/2mL injection, solution, listed with the FDA by Eli Lilly and Company. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Ebglyss (Lebrikizumab-lbkz).
- What is the active ingredient?
- Lebrikizumab.
- Who is the labeler?
- Eli Lilly and Company, NDC labeler code 0002. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Ebglyss?
- 1 other product NDC are listed under this name. See all Ebglyss NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Ebglyss products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Ebglysslebrikizumab-lbkz | Lebrikizumab 250 mg/2mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-7772 | 00002-7772-1100002-7772-62 |
Other NDCs under BLA 761306
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Ebglysslebrikizumab-lbkz | Lebrikizumab 250 mg/2mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-7772 |